Sharps Technology (STSS)
Markets syringe products while running a SOL-focused digital asset treasury.
Something off on this page? Send us feedback.
Sharps Technology is a Nasdaq-listed company marketing syringe products and related drug-delivery systems while operating a SOL-focused digital asset treasury. Its current profile depends on medical-device distribution, staking and custody infrastructure, and the volatility and regulatory treatment of digital assets.
Sharps Technology began as a medical-device company built around smart-safety and prefillable syringe products. Its latest filings describe a narrower operating model: marketing and distributing syringe products and related drug-delivery systems, with prior design and manufacturing activities moved away from the core business. In August 2025, the company adopted a digital asset treasury strategy centered on SOL, the native asset of the Solana blockchain, and now reports separate medical device and digital asset treasury segments.
The medical device segment manages sales and distribution, while the treasury segment manages the SOL platform through staking, validators, custodians, and related infrastructure. The business has therefore shifted from a pure syringe-device story to a hybrid medical-device and crypto-treasury issuer. Key dependencies include execution of the treasury strategy, secure custody, regulatory treatment of digital assets, SOL market liquidity, and the company's ability to keep a viable medical-device distribution channel.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $12.1M · Total debt $0 · Total assets $160.4M · Shareholders' equity $157.3M
- Revenue
- $2.3M
- Operating income
- −$23.4M
- Net income
- −$23.3M
No dividends on record.
| Institutions | ≥ 32.61% | 14.02M shares | |
|---|---|---|---|
| 30 holders · as of Jun 30, 2026 | |||
| Insiders | 0.08% | 35.6K shares | |
| 3 holders · as of Oct 6, 2025 | |||
| Strategic holders | 2.59% | 1.12M shares | |
| 1 holder · as of Feb 13, 2026 | |||
| Other | ≤ 64.72% | 27.81M shares | |
| remainder | |||
42.98M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Institutional filings for SKYA (100% of the company) are not on file here, so the institutional figure is a floor.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Electric Capital Partners, LLCInstitution | 6.10% | 2.62M | as of Jun 30, 2026 |
Parafi Capital LPInstitution | 5.00% | 2.15M | as of Jun 30, 2026 |
Saba Capital Management, L.P.Institution | 3.52% | 1.51M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 3.24% | 1.39M | as of Jun 30, 2026 |
Pantera Capital Partners LPInstitution | 2.68% | 1.15M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jan 12, 2026 | FalconX Holdings Ltd | 10 percent owner | −47,281 | $1.97 |
| Jan 9, 2026 | FalconX Holdings Ltd | 10 percent owner | −529,732 | $1.93 |
| Jan 16, 2026 | Saba Capital Management, L.P. | 10 percent owner | −12,182 | $2.37 |
| Jan 15, 2026 | Saba Capital Management, L.P. | 10 percent owner | −25,000 | $2.30 |
| Jan 14, 2026 | Saba Capital Management, L.P. | 10 percent owner | −77,688 | $2.25 |
Not reported.